Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
The Journal of Investigative Dermatology
|
March 1, 1997
A novel dinucleotide mutation in keratin 10 in the annular epidermolytic ichthyosis variant of bullous congenital ichthyosiform erythroderma
G Y Joh, H Traupe, D Metze, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 19, 2011
Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology Group
A Pflugfelder, A-K Welter, U Leiter, et al.
The British Journal of Dermatology
|
April 20, 2012
Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cells
M Felcht, M Heck, C Weiss, et al.
The British Journal of Dermatology
|
December 16, 2014
Actual practice of melanoma follow-up and treatment in Germany: results of a prospective, longitudinal cohort study
E Livingstone, T K Eigentler, C Windemuth-Kieselbach, et al.
British Journal of Cancer
|
April 20, 2001
Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG)
A Hauschild, C Garbe, W Stolz, et al.
Leukemia
|
November 23, 2007
Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3
N Booken, A Gratchev, J Utikal, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 24, 2024
Checkpoint inhibitor-induced bullous pemphigoid differs from spontaneous bullous pemphigoid
N Kramer, G Müller, S Zierold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 12, 2016
Adjuvant treatment with pegylated interferon α-2a versus low-dose interferon α-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial
T K Eigentler, R Gutzmer, A Hauschild, et al.
Journal of Cancer Research and Clinical Oncology
|
July 5, 2023
Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial)
Katharina C Kähler, S Hüning, D Nashan, et al.
The British Journal of Dermatology
|
November 18, 2003
Diagnostic and neural analysis of skin cancer (DANAOS). A multicentre study for collection and computer-aided analysis of data from pigmented skin lesions using digital dermoscopy
K Hoffmann, T Gambichler, A Rick, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
The Journal of Investigative Dermatology
|
March 1, 1997
A novel dinucleotide mutation in keratin 10 in the annular epidermolytic ichthyosis variant of bullous congenital ichthyosiform erythroderma
G Y Joh, H Traupe, D Metze, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 19, 2011
Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology Group
A Pflugfelder, A-K Welter, U Leiter, et al.
The British Journal of Dermatology
|
April 20, 2012
Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cells
M Felcht, M Heck, C Weiss, et al.
The British Journal of Dermatology
|
December 16, 2014
Actual practice of melanoma follow-up and treatment in Germany: results of a prospective, longitudinal cohort study
E Livingstone, T K Eigentler, C Windemuth-Kieselbach, et al.
British Journal of Cancer
|
April 20, 2001
Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG)
A Hauschild, C Garbe, W Stolz, et al.
Leukemia
|
November 23, 2007
Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3
N Booken, A Gratchev, J Utikal, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 24, 2024
Checkpoint inhibitor-induced bullous pemphigoid differs from spontaneous bullous pemphigoid
N Kramer, G Müller, S Zierold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 12, 2016
Adjuvant treatment with pegylated interferon α-2a versus low-dose interferon α-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial
T K Eigentler, R Gutzmer, A Hauschild, et al.
Journal of Cancer Research and Clinical Oncology
|
July 5, 2023
Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial)
Katharina C Kähler, S Hüning, D Nashan, et al.
The British Journal of Dermatology
|
November 18, 2003
Diagnostic and neural analysis of skin cancer (DANAOS). A multicentre study for collection and computer-aided analysis of data from pigmented skin lesions using digital dermoscopy
K Hoffmann, T Gambichler, A Rick, et al.
Page
of 8